241 related articles for article (PubMed ID: 36339343)
1. Engineered 5-HT producing gut probiotic improves gastrointestinal motility and behavior disorder.
Li B; Li M; Luo Y; Li R; Li W; Liu Z
Front Cell Infect Microbiol; 2022; 12():1013952. PubMed ID: 36339343
[TBL] [Abstract][Full Text] [Related]
2. Shouhui Tongbian Capsule ameliorates constipation via gut microbiota-5-HT-intestinal motility axis.
Bai J; Cai Y; Huang Z; Gu Y; Huang N; Sun R; Zhang G; Liu R
Biomed Pharmacother; 2022 Oct; 154():113627. PubMed ID: 36058152
[TBL] [Abstract][Full Text] [Related]
3. Improvement of loperamide-hydrochloride-induced intestinal motility disturbance by
Hao M; Song J; Zhai X; Cheng N; Xu C; Gui S; Chen J
Front Cell Infect Microbiol; 2023; 13():1105272. PubMed ID: 36992686
[TBL] [Abstract][Full Text] [Related]
4. An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
Gu P; Xie L; Chen T; Yang Q; Zhang X; Liu R; Guo J; Wei R; Li D; Jiang Y; Chen Y; Gong W; Chen P
J Hepatol; 2024 Mar; 80(3):454-466. PubMed ID: 37952766
[TBL] [Abstract][Full Text] [Related]
5. Breaking barriers: bacterial-microalgae symbiotic systems as a probiotic delivery system.
Huang H; Liu X; Lang Y; Cui J; Zhong D; Zhou M
J Nanobiotechnology; 2024 Jun; 22(1):371. PubMed ID: 38918805
[TBL] [Abstract][Full Text] [Related]
6. The probiotic fermented milk of Lacticaseibacillus paracasei JY062 and Lactobacillus gasseri JM1 alleviates constipation via improving gastrointestinal motility and gut microbiota.
Cheng S; Li B; Ding Y; Hou B; Hung W; He J; Jiang Y; Zhang Y; Man C
J Dairy Sci; 2024 Apr; 107(4):1857-1876. PubMed ID: 37923200
[TBL] [Abstract][Full Text] [Related]
7. Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.
Makizaki Y; Uemoto T; Yokota H; Yamamoto M; Tanaka Y; Ohno H
PLoS One; 2021; 16(3):e0248584. PubMed ID: 33750988
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects resulting from oral administration of
Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
[TBL] [Abstract][Full Text] [Related]
9. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery.
Zhou J; Li M; Chen Q; Li X; Chen L; Dong Z; Zhu W; Yang Y; Liu Z; Chen Q
Nat Commun; 2022 Jun; 13(1):3432. PubMed ID: 35701435
[TBL] [Abstract][Full Text] [Related]
10. Probiotic
Teng G; Liu Z; Liu Y; Wu T; Dai Y; Wang H; Wang W
Front Microbiol; 2022; 13():819336. PubMed ID: 35602072
[TBL] [Abstract][Full Text] [Related]
11. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
[TBL] [Abstract][Full Text] [Related]
12. Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut.
Crook N; Ferreiro A; Gasparrini AJ; Pesesky MW; Gibson MK; Wang B; Sun X; Condiotte Z; Dobrowolski S; Peterson D; Dantas G
Cell Host Microbe; 2019 Apr; 25(4):499-512.e8. PubMed ID: 30926240
[TBL] [Abstract][Full Text] [Related]
13. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.
Wang Y; Sun L; Chen S; Guo S; Yue T; Hou Q; Feng M; Xu H; Liu Y; Wang P; Pan Y
Life Sci; 2019 Aug; 231():116529. PubMed ID: 31173781
[TBL] [Abstract][Full Text] [Related]
14. Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance.
Nzakizwanayo J; Dedi C; Standen G; Macfarlane WM; Patel BA; Jones BV
Sci Rep; 2015 Nov; 5():17324. PubMed ID: 26616662
[TBL] [Abstract][Full Text] [Related]
15. Effects of Serotonin and Slow-Release 5-Hydroxytryptophan on Gastrointestinal Motility in a Mouse Model of Depression.
Israelyan N; Del Colle A; Li Z; Park Y; Xing A; Jacobsen JPR; Luna RA; Jensen DD; Madra M; Saurman V; Rahim R; Latorre R; Law K; Carson W; Bunnett NW; Caron MG; Margolis KG
Gastroenterology; 2019 Aug; 157(2):507-521.e4. PubMed ID: 31071306
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of cadmium- and mercury-induced liver and kidney damage in rats by genetically engineered probiotic Escherichia coli Nissle 1917 producing pyrroloquinoline quinone with oral supplementation of citric acid.
Raghuvanshi R; Chaudhari A; Kumar GN
Nutrition; 2016; 32(11-12):1285-94. PubMed ID: 27209211
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of gut dysbiosis and gastrointestinal motility by konjac oligo-glucomannan on loperamide-induced constipation in mice.
Hayeeawaema F; Wichienchot S; Khuituan P
Nutrition; 2020 May; 73():110715. PubMed ID: 32135415
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Loperamide-Induced Constipation in Mice and Alteration of 5-Hydroxytryotamine Signaling by
Qiu B; Zhu L; Zhang S; Han S; Fei Y; Ba F; Berglund B; Li L; Yao M
Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235735
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Serotonin-Related Genes by Extracellular Vesicles of the Probiotic
Olivo-Martínez Y; Martínez-Ruiz S; Cordero-Alday C; Bosch M; Badia J; Baldoma L
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791376
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation.
Dimidi E; Christodoulides S; Scott SM; Whelan K
Adv Nutr; 2017 May; 8(3):484-494. PubMed ID: 28507013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
